International Isotopes Inc. And RadQual LLC Announce the Start of Sales of the New "RadLite(TM)" Lightweight Flood Source


The new product is 60% lighter and 60% thinner than the original flood source design.



IDAHO FALLS, Idaho, – International Isotopes Inc. (OTC Bulletin Board: INIS) (the Company) and RadQual LLC (RadQual) today announced that they have obtained approval from the United States Nuclear Regulatory Commission (NRC) for their new lightweight flood source and will be making the new RadLite™ available to customers starting April 1, 2014.  This new product is 60% lighter and 60% thinner than the original flood source design and has been extensively tested to ensure it provides the same high quality that customers expect from RadQual's product line.  The Company owns a 24.5% interest in RadQual, and the Company has an exclusive manufacturing agreement with RadQual for the manufacturing of nuclear medicine products.



Steve T. Laflin, President and CEO of the Company stated, "We are pleased to be able to manufacture this new product for RadQual and expect it will be a very popular item for its customers." 



Peter Ouimette, Managing Partner of RadQual LLC stated, "The new innovative RadLite™ is designed to provide our clients with an easier to use flood source that we believe ensures that they receive the same high quality, safety and reliability that they expect from all RadQual products."  



About International Isotopes Inc.

International Isotopes Inc. manufactures RadQual's product line of nuclear medicine calibration and reference standards, a variety of cobalt-60 products, and provides a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, and industrial applications.



About RadQual LLC

Since 2001, RadQual has been an innovative developer of SPECT/PET imaging calibration and reference standards for quality control in Molecular Imaging Equipment.  RadQual's high quality products are distributed throughout the United States and worldwide by a select group of dealers and nuclear pharmacies.



FOR MORE INFORMATION CONTACT:



David Drewitz

Creative Options Communications

Investor and Public Relations

david@creativeoptionscommunications.com

www.creativeoptionsmarketing.com

Phone:  972-814-5723


All Topics